Abingdon Health (LON:ABDX) Trading Up 10.5% – Should You Buy?

Abingdon Health Plc (LON:ABDX) shot up 10.5% during trading on Monday . The stock traded as high as GBX 10.50 and last traded at GBX 10.48. 871,911 shares changed hands during mid-day trading, an increase of 354% from the average session volume of 191,899 shares. The stock had previously closed at GBX 9.48.

Abingdon Health Stock Up 8.9%

The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The firm has a market capitalization of £25.92 million, a P/E ratio of -12.74 and a beta of 0.25. The company’s fifty day simple moving average is GBX 7.47 and its 200 day simple moving average is GBX 6.85.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Tuesday, March 17th. The company reported GBX (0.43) EPS for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.